C1ORF9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.105800E-01
Normal-vs-Stage2
3.239600E-01
Normal-vs-Stage3
5.025600E-01
Normal-vs-Stage4
1.919190E-01
Stage1-vs-Stage2
2.638400E-01
Stage1-vs-Stage3
7.412400E-02
Stage1-vs-Stage4
9.914200E-01
Stage2-vs-Stage3
1.182210E-01
Stage2-vs-Stage4
6.607500E-02
Stage3-vs-Stage4
1.365390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.368800E-01
Normal-vs-AfricanAmerican
6.032300E-02
Normal-vs-Asian
3.282400E-01
Caucasian-vs-AfricanAmerican
8.407500E-02
Caucasian-vs-Asian
5.904800E-01
AfricanAmerican-vs-Asian
3.316500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.953600E-01
Normal-vs-Female
3.333800E-01
Male-vs-Female
5.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.931600E-02
Normal-vs-Age(41-60Yrs)
1.687020E-01
Normal-vs-Age(61-80Yrs)
3.871800E-01
Normal-vs-Age(81-100Yrs)
7.399000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.550000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.862800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.799570E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.580200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.487800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.763000E-01
Normal-vs-Daily Drinker
7.477000E-01
Normal-vs-Weekly Drinker
4.130800E-01
Normal-vs-Occasional Drinker
1.395380E-01
Normal-vs-Social Drinker
3.597600E-01
Non Drinker-vs-Daily Drinker
2.613400E-01
Non Drinker-vs-Weekly Drinker
8.043400E-01
Non Drinker-vs-Occasional Drinker
2.609500E-02
Non Drinker-vs-Social Drinker
3.799200E-01
Daily Drinker-vs-Weekly Drinker
4.659600E-01
Daily Drinker-vs-Occasional Drinker
6.317500E-03
Daily Drinker-vs-Social Drinker
1.406230E-01
Weekly Drinker-vs-Occasional Drinker
5.198500E-02
Weekly Drinker-vs-Social Drinker
3.216800E-01
Occasional Drinker-vs-Social Drinker
4.752800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.225700E-02
Normal-vs-Grade 2
1.292470E-02
Normal-vs-Grade 3
2.699500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.295600E-01
Grade 1-vs-Grade 3
7.564600E-01
Grade 1-vs-Grade 4
3.225700E-02
Grade 2-vs-Grade 3
3.477600E-01
Grade 2-vs-Grade 4
1.292470E-02
Grade 3-vs-Grade 4
2.699500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.390400E-01
Normal-vs-NonDiabetic
2.582400E-01
Diabetic-vs-NonDiabetic
1.164010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.324200E-01
Normal-vs-NoPancreatitis
3.209600E-01
Pancreatitis-vs-NoPancreatitis
3.979600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.810400E-01
Normal-vs-N1
3.417000E-01
N0-vs-N1
2.171600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.024200E-01
Normal-vs-TP53-NonMutant
1.731440E-01
TP53-Mutant-vs-TP53-NonMutant
2.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
